| BCBS Oklahoma Medical Policies | Work Hardening | 2024-04-01 |
| BCBS New Mexico Medical Policies | Compounded Drug Products | 2024-04-01 |
| BCBS New Mexico Medical Policies | Use of i-Factor Peptide Enhanced Bone Graft During Spinal | 2024-04-01 |
| BCBS New Mexico Medical Policies | Work Hardening | 2024-04-01 |
| BCBS New Mexico Medical Policies | Orthotics | 2024-04-01 |
| BCBS Montana Medical Policies | Compounded Drug Products | 2024-04-01 |
| BCBS Montana Medical Policies | Orthotics | 2024-04-01 |
| BCBS Montana Medical Policies | Use of i-Factor Peptide Enhanced Bone Graft During Spinal | 2024-04-01 |
| BCBS Montana Medical Policies | Work Hardening | 2024-04-01 |
| Medicare NCD | NCD 20.7 - Percutaneous Transluminal Angioplasty (PTA) | 2024-04-01 |